Boston Scientific Corporation
Boston Scientific Corporation’s Revenue Growth at a glance
Boston Scientific Corporation reports revenue growth of 17.6% for Dec 2024. The prior period recorded 12.3% (Dec 2023). Year over year the metric moved +5.3 pts (+43.3%). The rolling three-period average stands at 12.2%. Data last refreshed Dec 18, 2025, 5:29 AM.
Latest reading
17.6% · Dec 2024
YoY movement
+5.3 pts (+43.3%)
Rolling average
12.2%
Current Revenue Growth
17.6%
+5.3 pts
+43.3%
Rolling average
12.2%
Latest Value
17.6%
Dec 2024
YoY Change
+5.3 pts
Absolute
YoY Change %
+43.3%
Rate of change
3-Period Avg
12.2%
Smoothed
Narrative signal
Boston Scientific Corporation’s revenue growth stands at 17.6% for Dec 2024. Year-over-year, the metric shifted by +5.3 pts, translating into a +43.3% rate of change versus the prior period.
Pair this momentum with product cadence, pricing power, and capital allocation moves to understand durability.
Blend with balance sheet, cash flow, and peer benchmarks from AlphaPilot’s broader dashboards to shape an investable thesis.
How revenue growth shapes Boston Scientific Corporation's story
As of Dec 2024, Boston Scientific Corporation reports revenue growth of 17.6%. Evaluate revenue acceleration, seasonality, and long-term expansion for U.S. equities using annual growth data.
How to read revenue growth
Consistent double-digit revenue growth typically indicates demand strength and market share gains. Sharp decelerations may point to competitive or macro headwinds.
Balancing growth with profitability
Growth only creates value when paired with improving margins or cash generation. Pair revenue growth with profitability metrics to judge overall health.
Valuation Multiples
Compare how the market prices revenue, equity, and operating cash flow versus peers and history.
Profitability & Margins
Understand cost structure and capital efficiency trends across gross, operating, and net results.
Gross Margin
61.3%
Operating Margin
15.7%
Net Profit Margin
11.1%
Return on Equity
8.5%
Return on Assets
4.7%
Growth Momentum
Track whether top-line, earnings, and free cash flow growth are accelerating or cooling.
Balance Sheet Strength
Evaluate leverage, liquidity, and cash generation capacity that underpin resilience.
Shareholder Returns
Follow dividend sustainability and cash generation relative to market value.
Boston Scientific Corporation (BSX) FAQs
Answers tailored to Boston Scientific Corporation’s revenue growth profile using the latest Financial Modeling Prep data.
What is Boston Scientific Corporation's current revenue growth?
As of Dec 2024, Boston Scientific Corporation reports revenue growth of 17.6%. This reading reflects the latest filings and price data for BSX.
How is Boston Scientific Corporation's revenue growth trending year over year?
Year-over-year, the figure shifts by +5.3 pts (+43.3%). Pair this context with revenue growth and free cash flow signals to gauge momentum for BSX.
Why does revenue growth matter for Boston Scientific Corporation?
Revenue growth measures the percentage change in top-line sales compared with the prior period. For Boston Scientific Corporation, operating within Healthcare — Medical - Devices, tracking this metric helps benchmark management's execution against close competitors.
Is Boston Scientific Corporation's revenue growth above its recent average?
Boston Scientific Corporation's rolling three-period average sits at 12.2%. Comparing the latest reading of 17.6% to that baseline highlights whether momentum is building or fading for BSX.
How frequently is Boston Scientific Corporation's revenue growth refreshed?
Data for BSX was last refreshed on Dec 18, 2025, 5:29 AM and updates automatically every 24 hours, keeping your valuation inputs current.